CClinicalTrials.gg
CompletedNCT03850288InhibEatingUpdated Mar 6, 2023

Inhibitory Control and Eating Disorders

An observational study in Anorexia Nervosa, Bulimia Nervosa and Binge Eating, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to female participants aged 19 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-03-06.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
17
Ages
19 Years to 40 Years
Sex
Female
01

Study summary

Executive functions are part of the high-level cognitive processes essential to the proper functioning of human cognition. They consist mainly of flexibility, updating and inhibition. Some studies have shown a correlation between executive disorders (impaired executive function) and psychiatric disorders such as obsessive-compulsive disorder or phobias. These executive disorders are related to dysfunctions of the fronto-striatal loops.

In addition, other studies have investigated the link that may exist between eating disorders such as anorexia or bulimia nervosa and executive functioning. Anorexia nervosa, bulimia nervosa and binge eating disorders are eating disorders characterized by a dysfunction in food intake with restriction of food or compulsions as well as strong concerns about the body schema. Concerning the executive functioning, these studies highlight a lack of cognitive flexibility for patients with anorexia nervosa and bulimia nervosa but also dysfunctions depending on the type of pathology (anorexia nervosa or bulimia nervosa). These studies also highlight the beneficial effects of cognitive remediation on people with eating disorders.

However, the investigation of the inhibitory control has not yet been specifically studied. Moreover, since eating disorders are structurally different, a comparison between several pathologies would be interesting to consider.

The aim of this study is to determine if a dysfunction of inhibitory control can be highlighted in people with eating disorders. This study would also allow further researches about cognitive remediation suitable for the specific difficulties encountered in these diseases.

02

Conditions studied

03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's enrollment of 17 is below the median of 65 across 104 observational studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women aged 19 to 40 years old, with a BMI between 13 and 40 kg/m2, outpatients of the Refering Center of Eating Disorders ('Hospices Civils de Lyon' in Lyon), with an eating disorder diagnosis (Anorexia Nervosa, Bulimia Nervosa or Binge Eating Disorder).

Inclusion criteria

  • Woman aged 19 to 40 years old
  • Patient with a BMI between 13 and 40 kg/m2
  • Outpatients of the Refering Center of Eating Disorders ('Hospices Civils de Lyon' in Lyon) suffering of an eating disorder diagnosis (Anorexia Nervosa, Bulimia Nervosa or Binge Eating Disorder)
  • Patient who agrees to participate to the study.

Exclusion criteria

Exclusion Criteria:

  • Patient with psychiatric comorbidity severe (DSM V) and not stable (during the 8 weeks before inclusion)
  • Patient with psychotropic treatment (started or modified during the 8 weeks before inclusion)
  • Major patient protected by a measure of legal protection
  • Patient younger than 19 years old
  • Participation to another study at the same time
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
17 participants (actual)
Patient registry
No

Groups and cohorts

  • Anorexia Nervosa

    Patients with a diagnosis of anorexia nervosa (According to the DSM-V criteria). These patients are characterized by a restriction of food intake leading to weight loss or a failure to gain weight resulting in a "significantly low body weight" of what would be expected for someone's age, sex and height. Moreover, there is a fear of becoming fat or of gaining weight.Then, these patients have a distorted view of themselves and of their condition.

    Other: Neuropsychological assessment : Stroop task · Other: Neuropsychological assessment : Go No Go task

  • Bulimia Nervosa

    Patients with a diagnosis of bulimia nervosa. According to the DSM-V criteria, these patients are characterized by recurrent episodes of binge eating (eating, in a discrete period of time, an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances), a sense of lack of control over eating during the episode, recurrent inappropriate compensatory behaviour in order to prevent weight gain, such as self-induced vomiting, misuse of laxatives, diuretics, or other medications, fasting, or excessive exercise. The binge eating and inappropriate compensatory behaviours both occur, on average, at least once a week for three months. Moreover, there is a self-evaluation influenced by body shape and weight.

    Other: Neuropsychological assessment : Stroop task · Other: Neuropsychological assessment : Go No Go task

  • Binge Eating Disorder

    Patients with a diagnosis of Binge Eating Disorder. These patients are characterized by recurrent episodes of binge eating (eating, in a discrete period of time (e.g. within any 2-hour period), an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances), a sense of lack of control over eating during the episode. The binge eating episodes are associated with three or more of the following: eating much more rapidly than normal, eating until feeling uncomfortably full, eating large amounts of food when not feeling physically hungry, eating alone because of feeling embarrassed by how much one is eating, feeling disgusted with oneself, depressed or very guilty afterward,marked distress regarding binge eating is present. Moreover, binge eating occurs, on average, at least once a week for three months

    Other: Neuropsychological assessment : Stroop task · Other: Neuropsychological assessment : Go No Go task

Interventions

  • OtherNeuropsychological assessment : Stroop task

    Stroop task is an interference task assessing cognitive inhibitory control. This "paper-and-pencil" task aims to evaluate the inhibition of an automated process such as reading by asking participants to name the color of color names written in a different color ink. This test is non-invasive.

  • OtherNeuropsychological assessment : Go No Go task

    Go No Go task assessing motor inhibitory control. This computer-based task is designed to evaluate motor inhibition by asking participants to respond to a stimulus as quickly as possible by inhibiting another distractor stimulus. This test is non-invasive.

06

What researchers measure

Primary outcomes

  1. Inhibition processes assessment - the Stroop task, Execution time

    Execution time in the Stroop task

    Time frame: 1 day

  2. Inhibition processes assessment - the Stroop task, Errors

    Errors in the Stroop task

    Time frame: 1 day

  3. Inhibition processes assessment - the Go No Go task, Execution time

    Execution time in the Go No Go task.

    Time frame: 1 day

  4. Inhibition processes assessment - the Go No Go task, Variability of execution time

    Variability of execution time in the Go No Go task

    Time frame: 1 day

  5. Inhibition processes assessment - the Go No Go task, Errors

    Errors in the Go No Go task

    Time frame: 1 day

07

Study locations

1 site
  • Centre Référent pour l'Anorexie et les Troubles du Comportement Alimentaire
    Bron, 69500, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03850288
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Feb 21, 2019
Start date
May 15, 2019
Primary completion
Feb 26, 2020
Completion
Feb 26, 2020
Last update
Mar 6, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion